| Agios Pharmaceutical, Inc. | Common | $3.5M | 1.9% | 95,058 SH | New |
| Alkermes PLC | Common | $6.4M | 3.4%Prev: 0.6% | 121,759 SH | Increased+72,759 SH |
| AllianceBernstein Holding L.P. | Common | $1.7M | 0.9%Prev: 0.9% | 48,000 SH | Decreased |
| Alphabet Inc CL A | Common | $107K | 0.1%Prev: 0.0% | 300 SH | Increased |
| Alphabet Inc-Cl C | Common | $32.3M | 17.1%Prev: 9.0% | 91,420 SH | Increased-20,800 SH |
| Amazon.com Inc. | Common | $72K | 0.0%Prev: 0.0% | 300 SH | Increased |
| Apollo Global Management, Inc. | Common | $26.6M | 14.1%Prev: 14.5% | 225,000 SH | Decreased |
| Apple Inc. | Common | $722K | 0.4%Prev: 0.2% | 2,494 SH | Increased |
| Arcus Biosciences, Inc. | Common | $2.5M | 1.3%Prev: 0.3% | 81,241 SH | Increased+11,241 SH |
| Ardelyx, Inc. | Common | $1.3M | 0.7% | 263,168 SH | New |
| AtriCure, Inc. | Common | $1.4M | 0.8%Prev: 0.7% | 51,400 SH | Decreased+4,957 SH |
| Biogen Inc. | Common | $864K | 0.5% | 4,000 SH | New |
| Blackstone Group LP | Common | $25K | 0.0%Prev: 0.0% | 210 SH | Decreased |
| Boston Scientific Corporation | Common | $256K | 0.1% | 6,000 SH | New |
| Bridgebio Pharma, Inc. | Common | $6.9M | 3.7%Prev: 1.6% | 92,850 SH | Increased+12,850 SH |
| Bristol-Myers Squibb Company | Common | $115K | 0.1%Prev: 0.6% | 2,000 SH | Decreased-25,000 SH |
| Broadcom, Inc. | Common | $268K | 0.1%Prev: 0.1% | 710 SH | Increased |
| Canadian Natural Resources Limited | Common | $664K | 0.4%Prev: 0.2% | 16,800 SH | Increased |
| CareDx, Inc. | Common | $388K | 0.2% | 13,630 SH | New |
| Catalyst Pharmaceuticals, Inc. | Common | $3.6M | 1.9%Prev: 1.7% | 114,000 SH | Decreased-62,000 SH |
| Cogent Biosciences Inc. | Common | $4.3M | 2.3% | 111,081 SH | New |
| Connect Biopharma Holdings Limited | Common | $1.1M | 0.6% | 444,862 SH | New |
| Corteva, Inc. | Common | $102K | 0.1%Prev: 0.4% | 1,206 SH | Decreased-9,845 SH |
| Cullinan Therapeutics, Inc. | Common | $1.3M | 0.7% | 69,182 SH | New |
| Cybin Inc | Common | $2.4M | 1.3%Prev: 0.3% | 370,000 SH | Increased+303,120 SH |
| Danaher Corporation | Common | $34K | 0.0%Prev: 0.0% | 180 SH | Decreased |
| DocGo, Inc. | Common | $1.4M | 0.7%Prev: 2.2% | 2,670,850 SH | Decreased-400,000 SH |
| Dow Inc. | Common | $33K | 0.0%Prev: 0.0% | 1,206 SH | Increased |
| DuPont de Nemours, Inc. | Common | $511K | 0.3%Prev: 0.3% | 3,767 SH | Decreased-5,651 SH |
| Eastern Bankshares Inc | Common | $111K | 0.1%Prev: 0.0% | 5,000 SH | Increased |
| Enliven Therapeutics, Inc. | Common | $314K | 0.2% | 6,183 SH | New |
| FS KKR Capital Corp. | Common | $30K | 0.0%Prev: 0.0% | 2,875 SH | Decreased |
| GE HealthCare Technologies Inc | Common | $3K | 0.0%Prev: 0.0% | 50 SH | Decreased |
| Insmed Incorporated | Common | $453K | 0.2% | 4,253 SH | New |
| International Business Machines | Common | $602K | 0.3%Prev: 0.3% | 2,142 SH | Decreased |
| International Game Technology PLC | Common | $27K | 0.0%Prev: 0.0% | 2,500 SH | Decreased |
| Invivyd, Inc. | Common | $87K | 0.0% | 100,000 SH | New |
| Iovance Biotherapeutics, Inc. | Common | $6.7M | 3.5% | 1,600,000 SH | New |
| iShares Biotechnology ETF | Common | $1.0M | 0.6% | 5,500 SH | New |
| iShares Russell Mid-Cap Growth | Common | $102K | 0.1%Prev: 0.0% | 695 SH | Increased |
| Janus Henderson AAA CLO ETF | Common | $4.7M | 2.5%Prev: 11.4% | 93,528 SH | Decreased-401,726 SH |
| Johnson & Johnson | Common | $1.3M | 0.7%Prev: 0.5% | 4,922 SH | Increased-2,000 SH |
| JPMorgan Chase & Co. | Common | $5.9M | 3.1%Prev: 2.8% | 18,098 SH | Decreased-2,887 SH |
| Kimberly-Clark Corporation | Common | $263K | 0.1%Prev: 0.4% | 2,400 SH | Decreased-3,600 SH |
| Kura Oncology, Inc. | Common | $579K | 0.3% | 52,767 SH | New |
| Kyndryl Holdings Inc. | Common | $5K | 0.0%Prev: 0.0% | 428 SH | Decreased |
| LB Pharmaceuticals, Inc. | Common | $421K | 0.2% | 12,965 SH | New |
| Legacy Housing Corporation | Common | $105K | 0.1%Prev: 0.0% | 4,000 SH | Increased |
| LPL Financial Holdings Inc. | Common | $4.6M | 2.5% | 16,500 SH | New |
| Madrigal Pharmaaceuticals, Inc. | Common | $1.6M | 0.9%Prev: 0.3% | 3,000 SH | Increased+1,000 SH |
| Microsoft Corporation | Common | $597K | 0.3%Prev: 0.4% | 1,600 SH | Decreased |
| Mondelez International, Inc. | Common | $174K | 0.1% | 3,000 SH | New |
| Nvidia Corp | Common | $256K | 0.1%Prev: 0.1% | 1,280 SH | Increased |
| Occidental Petroleum Corporation | Common | $23K | 0.0%Prev: 0.0% | 469 SH | Increased |
| Occidential Pertro Wts exp. 8/3/27 | Common | $4K | 0.0%Prev: 0.0% | 194 SH | |
| Orchestra Biomed Holdings, Inc. | Common | $1.1M | 0.6%Prev: 0.1% | 253,651 SH | Increased+153,651 SH |
| Pelthos Therapeutics, Inc. | Common | $624K | 0.3% | 22,073 SH | New |
| Pfizer Inc. | Common | $779K | 0.4%Prev: 0.8% | 32,337 SH | Decreased-42,200 SH |
| Protagonist Therapeutics, Inc | Common | $7.7M | 4.1%Prev: 2.0% | 63,000 SH | Increased-17,000 SH |
| Q32 Bio Inc | Common | $387K | 0.2% | 30,412 SH | New |
| Quanta Services, Inc. | Common | $127K | 0.1%Prev: 0.0% | 176 SH | Increased |
| Rain Enhancement Technologies Holdco Inc | Common | $210K | 0.1% | 101,686 SH | New |
| Relmada Therapeutics, Inc. | Common | $3.1M | 1.6% | 451,000 SH | New |
| Rezolute, Inc. | Common | $1.9M | 1.0% | 370,000 SH | New |
| Ryman Hospitality Properties, Inc. | Common | $309K | 0.2%Prev: 0.5% | 2,400 SH | Decreased-9,600 SH |
| Salesforce, Inc. | Common | $12K | 0.0%Prev: 0.0% | 77 SH | Decreased |
| Solid Bioscience Inc. | Common | $562K | 0.3%Prev: 0.4% | 56,208 SH | Decreased-106,232 SH |
| SPDR S&P Biotech ETF | Common | $2.4M | 1.3%Prev: 0.1% | 15,000 SH | Increased+12,000 SH |
| Spruce Biosciences, Inc. | Common | $1.1M | 0.6% | 20,000 SH | New |
| Starwood Property Trust, Inc. | Common | $7K | 0.0%Prev: 0.0% | 400 SH | Decreased |
| Syndax Pharmaceutical, Inc. | Common | $9.6M | 5.1%Prev: 1.5% | 437,245 SH | Increased+84,467 SH |
| TG Therapeutics, Inc. | Common | $3.7M | 1.9% | 66,839 SH | New |
| The Panagram BBB-B CLO ETF | Common | $1.3M | 0.7%Prev: 0.6% | 47,807 SH | Decreased |
| Thermo Fisher Scientific, Inc. | Common | $23K | 0.0%Prev: 0.0% | 45 SH | Increased |
| Travere Therapeutics, Inc. | Common | $8.4M | 4.4%Prev: 1.7% | 147,282 SH | Increased-112,718 SH |
| Ultragenyx Pharmaceutical Inc. | Common | $1.3M | 0.7%Prev: 0.9% | 38,069 SH | Decreased-13,931 SH |
| United Healthcare Corp. | Common | $24K | 0.0%Prev: 0.0% | 57 SH | Increased |
| United Rental, Inc. | Common | $88K | 0.0%Prev: 0.0% | 78 SH | Increased |
| Vera Therapeutics, Inc. | Common | $1.1M | 0.6%Prev: 0.2% | 26,000 SH | Increased+6,000 SH |
| Verastem Inc. | Common | $592K | 0.3% | 155,000 SH | New |
| Viridian Therapeutics, Inc. | Common | $3.3M | 1.8%Prev: 0.6% | 181,000 SH | Increased+89,517 SH |
| Wabtec Corporation | Common | $2K | 0.0%Prev: 0.0% | 6 SH | Increased |
| Wave Life Science Ltd. | Common | $232K | 0.1%Prev: 0.1% | 40,000 SH | Decreased |
| Xeris Biopharma Holdings, Inc. | Common | $8.4M | 4.4%Prev: 2.2% | 1,060,000 SH | Increased |